Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Typhoid Fever - Overview
Typhoid Fever - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Typhoid Fever - Therapeutics Assessment
Assessment by Target
Assessment by Route of Administration
Assessment by Molecule Type
Typhoid Fever - Companies Involved in Therapeutics Development
Enesi Pharma Ltd
Eubiologics Co Ltd
GlaxoSmithKline Plc
Indian Immunologicals Ltd
Matrivax Research & Development Corp
Novo Medi Sciences Pvt Ltd
Prokarium Ltd
Protein Potential LLC
Sanofi Pasteur SA
Shantha Biotechnics Pvt Ltd
Walvax Biotechnology Co Ltd
Typhoid Fever - Drug Profiles
(paratyphoid (bivalent) + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
(paratyphoid + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
(rotavirus (virus like particle) + typhiod) vaccine - Drug Profile
Product Description
Mechanism Of Action
(shigella + typhoid) (Bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
(Streptococcal pneumonia + typhoid) vaccine - Drug Profile
Product Description
Mechanism Of Action
EUC-002 - Drug Profile
Product Description
Mechanism Of Action
History of Events
infectious disease vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
Typhax - Drug Profile
Product Description
Mechanism Of Action
History of Events
Typhella - Drug Profile
Product Description
Mechanism Of Action
History of Events
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
typhoid vaccine - Drug Profile
Product Description
Mechanism Of Action
typhoid Vi polysaccharide [strain S typhi Ty2] vaccine - Drug Profile
Product Description
Mechanism Of Action
ViCRM-197 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Typhoid Fever - Dormant Projects
Typhoid Fever - Discontinued Products
Typhoid Fever - Product Development Milestones
Featured News & Press Releases
Mar 26, 2021: Prokarium gains the cover of The Intertiol Jourl Of Molecular Science with the latest entervax publication
Dec 17, 2020: SK Bioscience-IVI jointly developed typhoid vaccine, secured successful phase 3 clinical results
Dec 17, 2020: IVI-SK’s new typhoid conjugate vaccine meets primary endpoints in phase III study in Nepal
Sep 17, 2020: Typhoid: Study confirms Vi-DT conjugate vaccine is safe and immunogenic in children 6-23 months of age
Jul 14, 2020: Prokarium obtains notice of allowance for US patent covering the modification of an attenuated strain of salmonella enterica serovar typhi to develop a vaccine against enteric fever
Nov 26, 2019: Prokarium announces MHRA acceptance to run phase i trial of lead vaccine against enteric fever
Oct 08, 2019: Prokarium secures ?4.6M from Wellcome to fund the clinical development of its lead vaccine programme
Oct 08, 2012: Typhim Vi - Typhoid Polysaccharide Vaccine - antigen levels below required specification
Oct 05, 2012: Sanofi Pasteur Voluntarily Recalls Few Batches Of Typhoid Fever Vaccine
Jun 23, 2011: Sanofi Pasteur’s Typhim Vi Receives Prequalification From World Health Organization
Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
Jan 08, 2008: Emergent BioSolutions Announces Fil Phase II Clinical Study Results for Typhoid Vaccine
Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine
Aug 30, 2005: Emergent Biosolutions’ Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study
Nov 29, 1994: Food And Drug Administration Grants License For A New Typhoid Fever Vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Typhoid Fever, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Typhoid Fever, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Typhoid Fever - Pipeline by Enesi Pharma Ltd, 2022
Typhoid Fever - Pipeline by Eubiologics Co Ltd, 2022
Typhoid Fever - Pipeline by GlaxoSmithKline Plc, 2022
Typhoid Fever - Pipeline by Indian Immunologicals Ltd, 2022
Typhoid Fever - Pipeline by Matrivax Research & Development Corp, 2022
Typhoid Fever - Pipeline by Novo Medi Sciences Pvt Ltd, 2022
Typhoid Fever - Pipeline by Prokarium Ltd, 2022
Typhoid Fever - Pipeline by Protein Potential LLC, 2022
Typhoid Fever - Pipeline by Sanofi Pasteur SA, 2022
Typhoid Fever - Pipeline by Shantha Biotechnics Pvt Ltd, 2022
Typhoid Fever - Pipeline by Walvax Biotechnology Co Ltd, 2022
Typhoid Fever - Dormant Projects, 2022
Typhoid Fever - Discontinued Products, 2022